Drug comparisons
Miglitol vs Tolbutamide
Miglitol slows intestinal glucose absorption as an alpha-glucosidase inhibitor, while Tolbutamide increases insulin release as a sulfonylurea for type 2 diabetes management.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes may compare Miglitol, an alpha-glucosidase inhibitor, and Tolbutamide, a sulfonylurea, when selecting between agents targeting postprandial versus fasting hyperglycemia.
Bottom line
Miglitol and Tolbutamide are distinct oral antidiabetic agents with different mechanisms of action, and the preferred medication depends on the patient's specific needs and glycemic targets.
All medication comparisons